In the context of gut permeability and dysbiosis, the downregulation of genes in the BC-treated Ztm male group versus the Ztm male control group, especially Cd14, Dusp6, and Nfkbiz, suggests that BC treatment may have an impact on attenuating the inflammatory response. Here, NFKBIZ is linked to breast cancer.